K Bilodeau1,2, D Tremblay2,3, M J Durand2,3,4. 1. Faculty of Nursing, Université de Montréal, Montreal, QC. 2. Faculty of Medicine and Health Sciences, Université de Sherbrooke, Longueuil, QC. 3. Hôpital Charles-LeMoyne Research Centre, Longueuil, QC. 4. Centre for Action in Work Disability Prevention and Rehabilitation, Longueuil, QC.
Abstract
Introduction: The number of survivors of breast cancer (bca) in Canada has steadily increased thanks to major advances in cancer care. But the resulting clientele face new challenges related to survivorship. The lack of continuity of care and the side effects of treatment affect the resumption of active life by survivors of bca, including return to work (rtw). The goal of the present article was to outline gaps and delay in survivorship care in the rtw pathway of survivors of bca. Methods: This qualitative interpretative descriptive study recruited 9 survivors of bca in the province of Quebec. Interviews were conducted at the end of cancer treatments (n = 9), 1 month before rtw (n = 9), and after rtw (n = 5). In an iterative process, a content analysis was performed. Results: The interviews highlighted gaps in survivorship care and the paucity of dedicated resources for cancer survivors. Participants received neither a survivorship care plan nor information about cancer survivorship (for example, transition to a new normal, side effects, rtw). Conclusions: Support for survivors of bca resuming their active lives has to be optimized. We suggest that health professionals have to intervene at 1, 3, and 6 months after cancer treatment. At those points, survivors of bca need support for side-effects management, the rtw decision, resource navigation, and reintegration of daily activities. Also, delay in clinical pathways seems to be longer, and much attention is needed to accompany the transition to a "normal life" after cancer.
Introduction: The number of survivors of breast cancer (bca) in Canada has steadily increased thanks to major advances in cancer care. But the resulting clientele face new challenges related to survivorship. The lack of continuity of care and the side effects of treatment affect the resumption of active life by survivors of bca, including return to work (rtw). The goal of the present article was to outline gaps and delay in survivorship care in the rtw pathway of survivors of bca. Methods: This qualitative interpretative descriptive study recruited 9 survivors of bca in the province of Quebec. Interviews were conducted at the end of cancer treatments (n = 9), 1 month before rtw (n = 9), and after rtw (n = 5). In an iterative process, a content analysis was performed. Results: The interviews highlighted gaps in survivorship care and the paucity of dedicated resources for cancer survivors. Participants received neither a survivorship care plan nor information about cancer survivorship (for example, transition to a new normal, side effects, rtw). Conclusions: Support for survivors of bca resuming their active lives has to be optimized. We suggest that health professionals have to intervene at 1, 3, and 6 months after cancer treatment. At those points, survivors of bca need support for side-effects management, the rtw decision, resource navigation, and reintegration of daily activities. Also, delay in clinical pathways seems to be longer, and much attention is needed to accompany the transition to a "normal life" after cancer.
Entities:
Keywords:
Survivorship; health care services; return to work
Authors: Greg Rubin; Annette Berendsen; S Michael Crawford; Rachel Dommett; Craig Earle; Jon Emery; Tom Fahey; Luigi Grassi; Eva Grunfeld; Sumit Gupta; Willie Hamilton; Sara Hiom; David Hunter; Georgios Lyratzopoulos; Una Macleod; Robert Mason; Geoffrey Mitchell; Richard D Neal; Michael Peake; Martin Roland; Bohumil Seifert; Jeff Sisler; Jonathan Sussman; Stephen Taplin; Peter Vedsted; Teja Voruganti; Fiona Walter; Jane Wardle; Eila Watson; David Weller; Richard Wender; Jeremy Whelan; James Whitlock; Clare Wilkinson; Niek de Wit; Camilla Zimmermann Journal: Lancet Oncol Date: 2015-09 Impact factor: 41.316
Authors: Mary Stergiou-Kita; Cheryl Pritlove; D Linn Holness; Bonnie Kirsh; Dwayne van Eerd; Andrea Duncan; Jennifer Jones Journal: J Cancer Surviv Date: 2016-01-27 Impact factor: 4.442